Copyright
©The Author(s) 2022.
World J Gastrointest Surg. Nov 27, 2022; 14(11): 1260-1271
Published online Nov 27, 2022. doi: 10.4240/wjgs.v14.i11.1260
Published online Nov 27, 2022. doi: 10.4240/wjgs.v14.i11.1260
Baseline (× 109/L) | Post-treatment (× 109/L) | Change (× 109/L) | |
Child-Pugh A (n = 8) | |||
mean ± SD | 41.75 ± 21.68 | 53.63 ± 34.13 | 11.88 ± 33.00 |
Median | 47.00 | 48.50 | 3.00 |
IQR | 23.00-55.75 | 39.25-62.25 | -6.00-38.50 |
Min, max | 6.00, 73.00 | 7.00, 127.00 | -34.00, 71.00 |
Child-Pugh B (n = 48) | |||
mean ± SD | 44.08 ± 17.01 | 105.88 ± 73.34 | 61.79 ± 69.53 |
Median | 46.50 | 82.00 | 50.50 |
IQR | 30.00-55.75 | 49.25-175.00 | 5.00-124.75 |
Min, max | 10.00, 80.00 | 7.00, 266.00 | -53.00, 214.00 |
Child-Pugh C (n = 44) | |||
mean ± SD | 42.00 ± 16.36 | 105.52 ± 94.30 | 63.52 ± 91.48 |
Median | 40.50 | 72.50 | 37.50 |
IQR | 33.25-51.75 | 47.00-139.75 | 6.25-104.00 |
Min, max | 9.00, 86.00 | 15.00, 489.00 | -36.00, 448.00 |
- Citation: Ding JN, Feng TT, Sun W, Cai XY, Zhang Y, Zhao WF. Recombinant human thrombopoietin treatment in patients with chronic liver disease-related thrombocytopenia undergoing invasive procedures: A retrospective study. World J Gastrointest Surg 2022; 14(11): 1260-1271
- URL: https://www.wjgnet.com/1948-9366/full/v14/i11/1260.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v14.i11.1260